Skip to main content
Erschienen in: The Cerebellum 5/2016

01.10.2016 | Original Paper

Carriage of One or Two FMR1 Premutation Alleles Seems to Have No Effect on Illness Severity in a FXTAS Female with an Autozygous FMR1 Premutation Allele

verfasst von: Laia Rodriguez-Revenga, Javier Pagonabarraga, Beatriz Gómez-Anson, Olga López-Mourelo, Silvia Izquierdo, Maria Isabel Alvarez-Mora, Esther Granell, Irene Madrigal, Montserrat Milà

Erschienen in: The Cerebellum | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder that occurs in FMR1 premutation carriers. The prevalence of FMR1 premutation carriers in the general population is relatively high, and although rare, a premutation in both X chromosomes may occur in females inheriting a premutation allele from each of both parent carriers. Here, we report the first female with an autozygous (homozygous by descendent) FMR1 premutation allele, who fulfills neurological and radiological FXTAS findings/criteria. Molecular characterization included CGG repeat length, AGG interruption pattern, FMR1 messenger RNA (mRNA), fragile X mental retardation protein (FMRP) level quantification, and single-nucleotide polymorphism (SNP) microarray. Neuroradiological assessment of 3-T magnetic resonance imaging and neurological and cognitive/neuropsychological evaluations were performed. Neurological and neuroradiological examination of the female with the same FMR1 allele in the premutation range (77 CGGs) demonstrated FXTAS features. Further familial evaluation showed a similar neuropsychiatric profile, with impairments in cognitive flexibility and visuospatial function, mainly. A unique family with an autozygous FMR1 premutation female is presented. Neurological/cognitive and neuroradiological examinations revealed FXTAS-specific findings in the female with the autozygous FMR1 premutation allele. The consistent molecular and cognitive/psychiatric phenotype in family members suggests that carrying one or two FMR1 premutation alleles has no effect on illness severity.
Literatur
1.
Zurück zum Zitat Coffey SM, Cook K, Tartaglia N, Tassone F, Nguyen DV, Pan R, et al. Expanded clinical phenotype of women with the FMR1 premutation. Am J Med Genet A. 2008;146A:1009–16.CrossRefPubMedPubMedCentral Coffey SM, Cook K, Tartaglia N, Tassone F, Nguyen DV, Pan R, et al. Expanded clinical phenotype of women with the FMR1 premutation. Am J Med Genet A. 2008;146A:1009–16.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Rodriguez-Revenga L, Madrigal I, Pagonabarraga J, Xunclà M, Badenas C, Kulisevsky J, et al. Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families. Eur J Hum Genet. 2009;17:1359–62.CrossRefPubMedPubMedCentral Rodriguez-Revenga L, Madrigal I, Pagonabarraga J, Xunclà M, Badenas C, Kulisevsky J, et al. Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families. Eur J Hum Genet. 2009;17:1359–62.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Jacquemont S, Hagerman RJ, Leehey MA, Hall DA, Levine RA, Brunberg JA, et al. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA. 2004;291:460–9.CrossRefPubMed Jacquemont S, Hagerman RJ, Leehey MA, Hall DA, Levine RA, Brunberg JA, et al. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA. 2004;291:460–9.CrossRefPubMed
4.
Zurück zum Zitat Rifé M, Badenas C, Mallolas J, Jiménez L, Cervera R, Maya A, et al. Incidence of fragile X in 5,000 consecutive newborn males. Genet Test. 2003;7:339–3343.CrossRefPubMed Rifé M, Badenas C, Mallolas J, Jiménez L, Cervera R, Maya A, et al. Incidence of fragile X in 5,000 consecutive newborn males. Genet Test. 2003;7:339–3343.CrossRefPubMed
5.
Zurück zum Zitat Tassone F, Iong KP, Tong TH, Lo J, Gane LW, Berry-Kravis E, et al. FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States. Genome Med. 2012;4:100.CrossRefPubMedPubMedCentral Tassone F, Iong KP, Tong TH, Lo J, Gane LW, Berry-Kravis E, et al. FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States. Genome Med. 2012;4:100.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Mazzocco MM, Holden JJ. Neuropsychological profiles of three sisters homozygous for the fragile X premutation. Am J Med Genet. 1996;64:323–8.CrossRefPubMed Mazzocco MM, Holden JJ. Neuropsychological profiles of three sisters homozygous for the fragile X premutation. Am J Med Genet. 1996;64:323–8.CrossRefPubMed
7.
Zurück zum Zitat Van Esch H, Buekenhout L, Race V, Matthijs G. Very early premature ovarian failure in two sisters compound heterozygous for the FMR1 premutation. Eur J Med Genet. 2009;52:37–40.CrossRefPubMed Van Esch H, Buekenhout L, Race V, Matthijs G. Very early premature ovarian failure in two sisters compound heterozygous for the FMR1 premutation. Eur J Med Genet. 2009;52:37–40.CrossRefPubMed
8.
Zurück zum Zitat Basuta K, Narcisa V, Chavez A, Kumar M, Gane L, Hagerman R, et al. Clinical phenotypes of a juvenile sibling pair carrying the fragile X premutation. Am J Med Genet A. 2011;155A:519–25.CrossRefPubMedPubMedCentral Basuta K, Narcisa V, Chavez A, Kumar M, Gane L, Hagerman R, et al. Clinical phenotypes of a juvenile sibling pair carrying the fragile X premutation. Am J Med Genet A. 2011;155A:519–25.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Basuta K, Lozano R, Schneider A, Yrigollen CM, Hessl D, Hagerman RJ, et al. A family with two female siblings with compound heterozygous FMR1 premutation alleles. Clin Genet. 2014;85:458–63.CrossRefPubMed Basuta K, Lozano R, Schneider A, Yrigollen CM, Hessl D, Hagerman RJ, et al. A family with two female siblings with compound heterozygous FMR1 premutation alleles. Clin Genet. 2014;85:458–63.CrossRefPubMed
10.
Zurück zum Zitat González JR, Rodríguez-Santiago B, Cáceres A, Pique-Regi R, Rothman N, Chanock SJ, et al. A fast and accurate method to detect allelic genomic imbalances underlying mosaic rearrangements using SNP array data. BMC Bioinform. 2011;12:166.CrossRef González JR, Rodríguez-Santiago B, Cáceres A, Pique-Regi R, Rothman N, Chanock SJ, et al. A fast and accurate method to detect allelic genomic imbalances underlying mosaic rearrangements using SNP array data. BMC Bioinform. 2011;12:166.CrossRef
11.
Zurück zum Zitat Willemsen R, Anar B, De Diego Otero Y, de Vries BB, Hilhorst-Hofstee Y, Smits A, et al. Noninvasive test for fragile X syndrome, using hair root analysis. Am J Hum Genet. 1999;65:98–103.CrossRefPubMedPubMedCentral Willemsen R, Anar B, De Diego Otero Y, de Vries BB, Hilhorst-Hofstee Y, Smits A, et al. Noninvasive test for fragile X syndrome, using hair root analysis. Am J Hum Genet. 1999;65:98–103.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.CrossRefPubMed Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.CrossRefPubMed
13.
Zurück zum Zitat Mattis S. Dementia rating scale: professional manual. Odessa: Psychological Assessment Resources; 1988. Mattis S. Dementia rating scale: professional manual. Odessa: Psychological Assessment Resources; 1988.
14.
Zurück zum Zitat Wechsler D. Wechsler Adult Intelligence Scale—3rd edition (WAIS-3®). San Antonio: Harcourt Assessment; 1997. Wechsler D. Wechsler Adult Intelligence Scale—3rd edition (WAIS-3®). San Antonio: Harcourt Assessment; 1997.
15.
Zurück zum Zitat Lezak MD, Howieson DB, Loring DW, Hannay HJ, Fischer JS. Neuropsychological assessment. 4th ed. New York: Oxford University Press; 2004. Lezak MD, Howieson DB, Loring DW, Hannay HJ, Fischer JS. Neuropsychological assessment. 4th ed. New York: Oxford University Press; 2004.
16.
Zurück zum Zitat Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a frontal assessment battery at bedside. Neurology. 2000;55:1621–6.CrossRefPubMed Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a frontal assessment battery at bedside. Neurology. 2000;55:1621–6.CrossRefPubMed
17.
Zurück zum Zitat Schmidt M. Rey auditory and verbal learning test: a handbook. Los Angeles: Western Psychological Services; 1996. Schmidt M. Rey auditory and verbal learning test: a handbook. Los Angeles: Western Psychological Services; 1996.
18.
Zurück zum Zitat Kaplan EFGH, Weintraub S. The Boston Naming Test. Boston: Kaplan and Goodglass; 1978. Kaplan EFGH, Weintraub S. The Boston Naming Test. Boston: Kaplan and Goodglass; 1978.
19.
Zurück zum Zitat Jacquemont S, Hagerman RJ, Leehey M, Grigsby J, Zhang L, Brunberg JA, et al. Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am J Hum Genet. 2003;72:869–78.CrossRefPubMedPubMedCentral Jacquemont S, Hagerman RJ, Leehey M, Grigsby J, Zhang L, Brunberg JA, et al. Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am J Hum Genet. 2003;72:869–78.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Yrigollen CM, Durbin-Johnson B, Gane L, Nelson DL, Hagerman R, Hagerman PJ, et al. AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome. Genet Med. 2012;14:729–36.CrossRefPubMedPubMedCentral Yrigollen CM, Durbin-Johnson B, Gane L, Nelson DL, Hagerman R, Hagerman PJ, et al. AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome. Genet Med. 2012;14:729–36.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Hagerman RJ, Leehey M, Heinrichs W, Tassone F, Wilson R, Hills J, et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology. 2001;57:127–30.CrossRefPubMed Hagerman RJ, Leehey M, Heinrichs W, Tassone F, Wilson R, Hills J, et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology. 2001;57:127–30.CrossRefPubMed
22.
Zurück zum Zitat Tassone F, Hagerman RJ. The fragile X-associated tremor ataxia syndrome. In: Denman RB, editor. Modeling fragile X syndrome, results and problems in cell differentiation 54. Berlin Heidelberg: Springer; 2012. p. 337–57.CrossRef Tassone F, Hagerman RJ. The fragile X-associated tremor ataxia syndrome. In: Denman RB, editor. Modeling fragile X syndrome, results and problems in cell differentiation 54. Berlin Heidelberg: Springer; 2012. p. 337–57.CrossRef
23.
Zurück zum Zitat Leehey MA, Berry-Kravis E, Goetz CG, Zhang L, Hall DA, Li L, et al. FMR1 CGG repeat length predicts motor dysfunction in premutation carriers. Neurology. 2008;70:1397–402.CrossRefPubMed Leehey MA, Berry-Kravis E, Goetz CG, Zhang L, Hall DA, Li L, et al. FMR1 CGG repeat length predicts motor dysfunction in premutation carriers. Neurology. 2008;70:1397–402.CrossRefPubMed
24.
Zurück zum Zitat Wheeler AC, Bailey Jr DB, Berry-Kravis E, Greenberg J, Losh M, Mailick M, et al. Associated features in females with an FMR1 premutation. J Neurodev Disord. 2014;6:30.CrossRefPubMedPubMedCentral Wheeler AC, Bailey Jr DB, Berry-Kravis E, Greenberg J, Losh M, Mailick M, et al. Associated features in females with an FMR1 premutation. J Neurodev Disord. 2014;6:30.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Eckert T, Tang C, Eidelberg D. Assessment of the progression of Parkinson’s disease: a metabolic network approach. Lancet Neurol. 2007;6:926–32.CrossRefPubMedPubMedCentral Eckert T, Tang C, Eidelberg D. Assessment of the progression of Parkinson’s disease: a metabolic network approach. Lancet Neurol. 2007;6:926–32.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Schrag A, Kingsley D, Phatouros C, Mathias CJ, Lees AJ, Daniel SE, et al. Clinical usefulness of magnetic resonance imaging in multiple system atrophy. J Neurol Neurosurg Psychiatry. 1998;65:65–71.CrossRefPubMedPubMedCentral Schrag A, Kingsley D, Phatouros C, Mathias CJ, Lees AJ, Daniel SE, et al. Clinical usefulness of magnetic resonance imaging in multiple system atrophy. J Neurol Neurosurg Psychiatry. 1998;65:65–71.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Lee WH, Lee CC, Shyu WC, Chong PN, Lin SZ. Hyperintense putaminal rim sign is not a hallmark of multiple system atrophy at 3T. AJNR Am J Neuroradiol. 2005;26:2238–42.PubMed Lee WH, Lee CC, Shyu WC, Chong PN, Lin SZ. Hyperintense putaminal rim sign is not a hallmark of multiple system atrophy at 3T. AJNR Am J Neuroradiol. 2005;26:2238–42.PubMed
Metadaten
Titel
Carriage of One or Two FMR1 Premutation Alleles Seems to Have No Effect on Illness Severity in a FXTAS Female with an Autozygous FMR1 Premutation Allele
verfasst von
Laia Rodriguez-Revenga
Javier Pagonabarraga
Beatriz Gómez-Anson
Olga López-Mourelo
Silvia Izquierdo
Maria Isabel Alvarez-Mora
Esther Granell
Irene Madrigal
Montserrat Milà
Publikationsdatum
01.10.2016
Verlag
Springer US
Erschienen in
The Cerebellum / Ausgabe 5/2016
Print ISSN: 1473-4222
Elektronische ISSN: 1473-4230
DOI
https://doi.org/10.1007/s12311-016-0783-z

Weitere Artikel der Ausgabe 5/2016

The Cerebellum 5/2016 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.